Unlocked Labs Inc

About

Unlocked Labs Inc is a pioneering pharmaceutical biotechnology company based in Laramie, Wyoming, specializing in next-generation probiotic development and precision microbial therapeutics. The company has developed an innovative approach to probiotic manufacturing that focuses on single-strain, targeted interventions designed to address specific metabolic compounds and toxin removal within the human body. Their flagship product, Strain OX164, represents a breakthrough in probiotic technology, specifically engineered to break down oxalic acid levels in the body. Unlike traditional multi-strain probiotics, Unlocked Labs utilizes a sophisticated manufacturing process that identifies probiotic strains with natural degradation potential, then activates and amplifies their compound-breaking capabilities through advanced biological tools and enzyme activation techniques. The company follows rigorous safety protocols using OECD best practices and maintains partnerships with prestigious organizations including the National Institutes of Health, National Science Foundation, and IndieBio accelerator program. Their shelf-stable formulations require no refrigeration, offering convenient daily serving sachets that can be taken directly or mixed with water. Unlocked Labs has gained recognition as one of only thirteen companies worldwide selected for IndieBio San Francisco accelerator program and has received NIH funding for market research. Located in Wyoming Technology Business Center, the company continues advancing precision probiotic manufacturing for targeted health outcomes and metabolic waste management solutions.